Axel Krebs‐Brown

Effectiveness and safety of ICL670 in iron-loaded patients with thalassaemia: a randomised, double-blind, placebo-controlled, dose-escalation trial

Eric Nisbet‐Brown, Nancy F. Olivieri, Patricia J. Giardina et al. · The Lancet · 2003 · 330 citations

Medicine, Hematology, Pharmacology +12

Effect of rifampicin on the pharmacokinetics of imatinib mesylate (Gleevec, STI571) in healthy subjects

Ann E. Bolton, Bin Peng, Martine Hubert et al. · Cancer Chemotherapy and Pharmacology · 2004 · 159 citations

Medicine, Pharmacokinetics, Pharmacology +6

A novel approach to identify responder subgroups and predictors of response to low‐ and high‐dose capsaicin patches in postherpetic neuralgia

Chris H. Martini, Ashraf Yassen, Axel Krebs‐Brown et al. · European Journal of Pain · 2013 · 57 citations

Nursing, Pharmacology, Pharmacotherapy +15

Evaluation of the CCK-4 model as a challenge paradigm in a population of healthy volunteers within a proof-of-concept study

Daniela Eser, Cornelius Schüle, Thomas C. Baghai et al. · Psychopharmacology · 2007 · 45 citations

Pharmacy, Health Sciences, Health Assessment +3

Comparison of three microbial assay procedures for measuring toxicity of chemical compounds: ToxAlert®10, CellSense and Biolog MT2 microplates

Luisa Freitas dos Santos, Ludwig Defrenne, Axel Krebs‐Brown · Analytica Chimica Acta · 2002 · 40 citations

Pharmacy, Microbiology, Toxicology +7